 WALTHAM, Mass., Sept. 12, 2022 GLOBE NEWSWIRE -- Apellis Pharmaceuticals , Inc. Nasdaq: APLS, a global biopharmaceutical company and leader in complement, today announced updated timing for its fireside chat at an upcoming investor conference hosted by Bank of America. 